Bijoya Mukherjee*

Department of Obstetrics and Gynecology, VMMC and Safdarjung Hospital, India

*Corresponding Author: Bijoya Mukherjee, Department of Obstetrics and Gynecology, VMMC and Safdarjung Hospital, India.

Received: December 26, 2023; Published: March 05, 2024

Abstract

Novel coronavirus (SARS CoV-2) has been creating a havoc since its advent in 2019. It was first identified in Wuhan, China and has now spread over several countries and affected millions of population. Several variants of SARS CoV-2 have come to light till date, the latest being the Omicron variant.

Keywords: COVID-19; SARS CoV-2; Pregnancy

References

1. Rasmussen SA., et al. “Effects of influenza on pregnant women and infants”. American Journal of Obstetrics and Gynecology3 (2012): S3-S8.
2. Knight M., et al. “ISARIC4C Consortium, UK Obstetric Surveillance System (UKOSS) and COVID-19 Clinical Information Network (CO-CIN). Females in hospital with SARS-CoV-2 infection, the association with pregnancy and pregnancy outcomes: A UKOSS/ISARIC/CO-CIN investigation”. (2021).
3. Allotey J., et al. “Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis”. BMJ 370 (2020): m3320.
4. Zambrano LD., et al. “Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22-October 3, 2020”. Morbidity and Mortality Weekly Report 44 (2020): 1641-1647.
5. Metz TD., et al. “Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19)”. Obstetrics and Gynecology4 (2021): 571-580.
6. Society for Maternal-Fetal Medicine (SMFM). COVID-19 and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know. Washington, DC: SMFM (2020).
7. Vousden N., et al. “Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort”. medRxiv (2021).
8. Ellington S., et al. “Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS- CoV-2 Infection by Pregnancy Status — United States, January 22-June 7, 2020”. MMWR Morbidity and Mortality Weekly Report (2020).
9. UK Health Security Agency. Investigation of SARS-CoV-2 variants: technical briefings.
10. Guan WY., et al. “Clinical characteristics of coronavirus disease 2019 in China”. The New England Journal of Medicine (2019).
11. Royal College of Obstetricians and Gynaecologists. Bacterial sepsis in pregnancy. Green- top Guideline No. 64a. (2012).
12. National Institute for Health and Care Excellence. COVID-19 rapid guideline: critical care in adults. NICE guideline 159 [NG159]. Updated 12 February 2021 (2020).
13. Scottish Intercollegiate Guidelines Network. COVID-19 position statement: Maternal critical care provision (2020).
14. MBRRACE-UK. “Saving Lives, Improving Mothers’ Care Rapid report: Learning from SARS-CoV2-related and associated maternal deaths in the UK”. March-May 2020. (2021).
15. gov. Randomised Evaluation of COVID-19 Therapy (RECOVERY). (2020).
16. Saad AF., et al. “Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)”. Obstetrics and Gynecology4 (2020): 823-826.
17. Beigel JH., et al. “Remdesivir for the Treatment of Covid-19 - Final Report”. The New England Journal of Medicine19 (2020): 1813-1826.
18. The RECOVERY Collaborative Group. “Dexamethasone in Hospitalized Patients with Covid-19”. The New England Journal of Medicine8 (2021): 693-704.
19. Saito J., et al. “Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum”. Rheumatology8 (2019): 1505-1507.
20. Sivapalasingam S., et al. “A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19”. medRxiv (2021).
21. The REMAP-CAP Investigators, Derde LPG. “Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial”. medRxiv (2021).
22. Chambers CD., et al. “Birth outcomes in women who have taken adalimumab in pregnancy:A prospective cohort study”. PloS one10 (2019): e0223603.
23. Gupta A., et al. “Early Treatment for Covid-19 with SARSCoV-2 Neutralizing Antibody Sotrovimab”. The New England Journal of Medicine (2021).
24. National Institute for Health and Care Excellence. “COVID-19 rapid guideline: managing COVID-19”. NICE guideline 191 [NG191]. (2021).
25. Zhang B., et al. “Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection”. Chest 1 (2020): e9-e13.
26. Costanzo G., et al. “Baricitinib exposure during pregnancy in rheumatoid arthritis”. Therapeutic Advances in Musculoskeletal Disease 12 (2020): 1759720X19899296.
27. Gavillet M., et al. “Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?” Ultrasound Obstetrics and Gynecology6 (2020): 843-844.
28. Lippi G., et al. “Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis”. Clinical Chimica Acta 506 (2020): 145-148.
29. Tolcher MC., et al. “Prone Positioning for Pregnant Women With Hypoxemia Due to Coronavirus Disease 2019 (COVID-19)”. Obstetrics and Gynecology2 (2020): 259-261.
30. National Institute for Health and Care Excellence. “Preterm labour and birth”. NICE guideline [NG25]. Updated 2 August 2019 (2015).
31. National Institute for Health and Care Excellence : Intrapartum Care for healthy women and babies. NICE Clinical Guideline 190 [CG190]. Updated 21 February 2017 (2014).
32. Mejía Jiménez I., et al. “Umbilical cord clamping and skin-to-skin contact in deliveries from women positive for SARS-CoV-2: a prospective observational study”. BJOG 5 (2021): 908-915.
33. National Institute for Health and Care Excellence. Postnatal care. NICE guideline 194 [NG194]. (2021).
34. Royal College of Midwives. “Optimising mother-baby contact and infant feeding in a pandemic”. Rapid review Version 2. (2020).
35. Berghella V and Hughes LB. “COVID-19: Pregnancy issues and antenatal care”. Uptodate, Jan 10 (2022).

Citation

Citation: Bijoya Mukherjee. “Critical Care Management in Covid 19 Infection in Pregnancy".Acta Scientific Women's Health 6.4 (2024): 08-12.

Copyright

Copyright: © 2024 Bijoya Mukherjee. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.